{"id":54601,"date":"2020-03-02T11:12:14","date_gmt":"2020-03-02T14:12:14","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=54601"},"modified":"2020-03-03T07:18:35","modified_gmt":"2020-03-03T10:18:35","slug":"hypera-pharma-compra-portfolio-medicamentos-takeda","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/","title":{"rendered":"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda"},"content":{"rendered":"<p>A <a href=\"https:\/\/www.suno.com.br\/acoes\/hype3\/\"><strong>Hypera Pharma<\/strong> (HYPE3)<\/a> confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da <strong>Takeda<\/strong> <strong>Pharmaceutical<\/strong> <strong>International<\/strong> por US$ 825 milh\u00f5es (cerca de R$ 3,7 bilh\u00f5es).<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled newsContent__article__imgCapa--noCaption\" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-800x450.webp\" width=\"800\" height=\"450\" alt=\"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--hide\">A Hypera apresentou um lucro l\u00edquido de R$ 345,6 milh\u00f5es referente ao terceiro trimestre de 2020<\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\n<p>O novo portf\u00f3lio de rem\u00e9dios, isentos de prescri\u00e7\u00e3o, adquiridos pela Hypera conta com os seguintes medicamentos: <strong>Neosaldina<\/strong>, <strong>Dramin<\/strong> e <strong>Nesina<\/strong>. A Hypera informou que j\u00e1 tratou com os bancos sobre as linhas de cr\u00e9dito que ser\u00e3o necess\u00e1rias para o financiamento da negocia\u00e7\u00e3o com a Takeda. A maior ind\u00fastria farmac\u00eautica do Brasil utilizar\u00e1 R$ 3,5 bilh\u00f5es para financiar a compra.<\/p>\n<p>\u201cA Hypera Pharma e a Takeda tamb\u00e9m assinar\u00e3o acordo de fabrica\u00e7\u00e3o e fornecimento em conex\u00e3o com a transa\u00e7\u00e3o, por meio do qual a Takeda continuar\u00e1 a fornecer produtos \u00e0 companhia\u201d, comunicou a Hypera. A farmac\u00eautica brasileira publicou em seu comunicado que a compra ser\u00e1 fechada no final de 2020.<\/p>\n<p><a href=\"https:\/\/www.suno.com.br\/noticias\/indicacao-a-conselho-irb-presenta-berskshire\/\">Veja tamb\u00e9m: Indica\u00e7\u00e3o a conselho do IRB (IRBR3) \u00e9 representante da Berkshire Hathaway no Brasil<\/a><\/p>\n<p>A Hypera Pharma ser\u00e1 a maior empresa farmac\u00eautica no Brasil ap\u00f3s a aquisi\u00e7\u00e3o da <strong>Buscopan<\/strong> e dos ativos da Takeda. A parte comprada da Takeda pela Hypera teve receita l\u00edquida de aproximadamente R$ 900 milh\u00f5es no ano passado.<\/p>\n<p>O portf\u00f3lio adquirido pela brasileira possui produtos das \u00e1reas de:<\/p>\n<ul>\n<li>cardiologia<\/li>\n<li><span style=\"font-size: 1.21429rem;\">diabetes<\/span><\/li>\n<li><span style=\"font-size: 1.21429rem;\">endocrinologia<\/span><\/li>\n<li><span style=\"font-size: 1.21429rem;\"> gastroenterologia<\/span><\/li>\n<li><span style=\"font-size: 1.21429rem;\"> sistema respirat\u00f3rio <\/span><\/li>\n<li><span style=\"font-size: 1.21429rem;\">cl\u00ednica geral\u00a0<\/span><\/li>\n<\/ul>\n<p>Vale destacar que a Hypera Pharma j\u00e1 \u00e9 dona da <strong>Neo Qu\u00edmica<\/strong> e da <strong>Montecorp<\/strong>, al\u00e9m de outros laborat\u00f3rios brasileiros.<\/p>\n<h2>Hypera Pharma adquire ativos da Boehringer Ingelheim<\/h2>\n<p>O conselho da Hypera\u00a0aprovou a compra de alguns ativos da <strong>Boehringer Ingelheim<\/strong> no Brasil, ao final do ano passado, como as marcas Buscopan e Buscofem, por R$ 1,3 bilh\u00e3o.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/minicurso-valuation\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Minicurso-Valuation.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Minicurso-Valuation.png\"\n\t\t\t\t\tdata-promo-id=\"383160\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Minicurso-Valuation.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>&#8220;O Buscopan atualmente \u00e9 a marca l\u00edder no segmento de antiespasm\u00f3dico no Brasil, e a fam\u00edlia Buscopan e <strong>Buscofem<\/strong> a segunda maior franquia no mercado de OTC no Pa\u00eds. O contato estabelece os termos para o fechamento e implementa\u00e7\u00e3o da aquisi\u00e7\u00e3o dos ativos, entre elas, a aprova\u00e7\u00e3o da autoridade antitruste e outras condi\u00e7\u00f5es relevantes&#8221;, informou o comunicado Hypera.<\/p>\n<p>Em outubro deste ano, a Boehringer j\u00e1 havia sinalizado o interesse em vender os produtos do Buscopan e Buscofem. A <strong>Hypera<\/strong>, entretanto,\u00a0destacou que essa opera\u00e7\u00e3o est\u00e1 alinhada com o objetivo estrat\u00e9gico da empresa.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda Pharmaceutical International por US$ 825 milh\u00f5es (cerca de R$ 3,7 bilh\u00f5es). A Hypera apresentou um lucro l\u00edquido de R$ 345,6 milh\u00f5es referente ao terceiro trimestre de 2020 O novo portf\u00f3lio de rem\u00e9dios, isentos de prescri\u00e7\u00e3o, adquiridos pela [&hellip;]<\/p>\n","protected":false},"author":19,"featured_media":32382,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[501],"suno_strategy":[],"class_list":["post-54601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-hypera-pharma-hype3"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina<\/title>\n<meta name=\"description\" content=\"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina\" \/>\n<meta property=\"og:description\" content=\"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1140\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Juliano Passaro\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Juliano Passaro\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\"},\"author\":{\"name\":\"Juliano Passaro\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/1db762f78ffd8919a648a63e425953e3\"},\"headline\":\"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda\",\"datePublished\":\"2020-03-02T14:12:14+00:00\",\"dateModified\":\"2020-03-03T10:18:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp\",\"keywords\":[\"Hypera Pharma (HYPE3)\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\",\"name\":\"Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp\",\"datePublished\":\"2020-03-02T14:12:14+00:00\",\"dateModified\":\"2020-03-03T10:18:35+00:00\",\"description\":\"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp\",\"width\":1140,\"height\":600,\"caption\":\"A Hypera apresentou um lucro l\u00edquido de R$ 345,6 milh\u00f5es referente ao terceiro trimestre de 2020\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/1db762f78ffd8919a648a63e425953e3\",\"name\":\"Juliano Passaro\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/743d4df28eebf6dcc46b4ad03c319e92?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/743d4df28eebf6dcc46b4ad03c319e92?s=96&r=g\",\"caption\":\"Juliano Passaro\"},\"description\":\"Juliano Passaro escreve sobre pol\u00edtica, economia e neg\u00f3cios para o portal da Suno Research. Antes da Suno, trabalhou no Portal da Band. \u00c9 formado em jornalismo pela Universidade Presbiteriana Mackenzie.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/juliano\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina","description":"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/","og_locale":"pt_BR","og_type":"article","og_title":"Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina","og_description":"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.","og_url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":1140,"height":600,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera.jpg","type":"image\/jpeg"}],"author":"Juliano Passaro","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Juliano Passaro","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/"},"author":{"name":"Juliano Passaro","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/1db762f78ffd8919a648a63e425953e3"},"headline":"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda","datePublished":"2020-03-02T14:12:14+00:00","dateModified":"2020-03-03T10:18:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/"},"wordCount":413,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp","keywords":["Hypera Pharma (HYPE3)"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/","url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/","name":"Hypera Pharma compra ativos da Takeda na Am\u00e9rica Latina","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp","datePublished":"2020-03-02T14:12:14+00:00","dateModified":"2020-03-03T10:18:35+00:00","description":"A Hypera Pharma (HYPE3) confirmou nesta segunda-feira (2) que adquiriu o portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda. Saiba mais.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-jpg.webp","width":1140,"height":600,"caption":"A Hypera apresentou um lucro l\u00edquido de R$ 345,6 milh\u00f5es referente ao terceiro trimestre de 2020"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/1db762f78ffd8919a648a63e425953e3","name":"Juliano Passaro","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/743d4df28eebf6dcc46b4ad03c319e92?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/743d4df28eebf6dcc46b4ad03c319e92?s=96&r=g","caption":"Juliano Passaro"},"description":"Juliano Passaro escreve sobre pol\u00edtica, economia e neg\u00f3cios para o portal da Suno Research. Antes da Suno, trabalhou no Portal da Band. \u00c9 formado em jornalismo pela Universidade Presbiteriana Mackenzie.","url":"https:\/\/www.suno.com.br\/noticias\/author\/juliano\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/07\/477bac07-hyphera-400x200.webp\" alt=\"Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-compra-portfolio-medicamentos-takeda\/\"><h2 class=\"content__title\">Hypera Pharma compra portf\u00f3lio de medicamentos sem prescri\u00e7\u00e3o da Takeda<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/juliano\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2019\/06\/7cc3efea-whatsapp-image-2019-07-18-at-21.59.33-e1563499821209-150x150.webp\" alt=\"Juliano Passaro\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/juliano\/\"><span itemprop=\"author\">Juliano Passaro<\/span><\/a><\/span><time datetime=\"2020-03-02T11:12:14-03:00\" itemprop=\"datePublished\">02\/03\/2020 11:12<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/54601"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=54601"}],"version-history":[{"count":0,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/54601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/32382"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=54601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=54601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=54601"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=54601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}